{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:07:22Z","timestamp":1790482042044,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Netherlands Heart Foundation","award":["2012T083"],"award-info":[{"award-number":["2012T083"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.atherosclerosis.2017.11.030","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T01:45:27Z","timestamp":1512179127000},"page":"152-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels"],"prefix":"10.1016","volume":"268","author":[{"given":"Swasti","family":"Indhirajanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.A.","family":"van Daele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique T.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilze","family":"Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine E.","family":"Roeters van Lennep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.11.030_bib1","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/S0735-1097(02)02834-6","article-title":"Mechanisms of plaque vulnerability and rupture","volume":"41","author":"Shah","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.11.030_bib2","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/01.STR.0000226901.34927.10","article-title":"Inflammation and atherosclerosis: novel insights into plaque formation and destabilization","volume":"37","author":"Stoll","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.030_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/ATVBAHA.114.303570","article-title":"Mast cells as effectors in atherosclerosis","volume":"35","author":"Bot","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.11.030_bib4","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1161\/01.CIR.90.4.1669","article-title":"Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture","volume":"90","author":"Kaartinen","year":"1994","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.11.030_bib5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.CIR.92.5.1084","article-title":"Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction","volume":"92","author":"Kovanen","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.030_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.CIR.99.3.361","article-title":"Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery","volume":"99","author":"Laine","year":"1999","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.11.030_bib7","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/01.CIR.101.14.1665","article-title":"Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary segments","volume":"101","author":"Laine","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.11.030_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0735-1097(98)00283-6","article-title":"Mast cell infiltration in acute coronary syndromes: implications for plaque rupture","volume":"32","author":"Kaartinen","year":"1998","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2017.11.030_bib9","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.106.660472","article-title":"Perivascular mast cells promote atherogenesis and induce plaque destabilization in apoE deficient mice","volume":"115","author":"Bot","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.11.030_bib10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1601","article-title":"Mast cells promote atherosclerosis by releasing proinflammatory cytokines","volume":"13","author":"Sun","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.11.030_bib11","series-title":"World Health Organization (WHO) Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues","first-page":"54","article-title":"Mastocytosis (mast cell disease)","author":"Horny","year":"2008"},{"key":"10.1016\/j.atherosclerosis.2017.11.030_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2016.01.005","article-title":"Systemic mastocytosis: a cohort study on clinical characteristics of 136 patients in a large tertiary centre","volume":"30","author":"Hermans","year":"2016","journal-title":"Eur. J. Intern Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.11.030_bib13","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe co-administered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"7404","key":"10.1016\/j.atherosclerosis.2017.11.030_bib14","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","article-title":"Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.030_bib15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2015.07.024","article-title":"Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia","volume":"242","author":"Bos","year":"2015","journal-title":"Atherosclerosis"},{"issue":"48","key":"10.1016\/j.atherosclerosis.2017.11.030_bib16","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/eurheartj\/eht186","article-title":"Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events","volume":"34","author":"Willems","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.11.030_bib17","article-title":"Mast cells are increased in the media of coronary lesions in patients with myocardial infarction and may favor atherosclerotic plaque instability","author":"Kupreishvili","year":"2016","journal-title":"J.\u00a0Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.11.030_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/ajh.24490","article-title":"Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: a nationwide population-based study","volume":"91","author":"Broesby-Olsen","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.030_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2009.07.027","article-title":"Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex\u00a0vivo","volume":"208","author":"Judstr\u00f6m","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.11.030_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/ATVBAHA.115.306827","article-title":"Carboxyl-terminal cleavage of apolipoprotein A-I by human mast cell chymase impairs its anti-inflammatory properties","volume":"36","author":"Nguyen","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.11.030_bib21","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.bbadis.2014.07.026","article-title":"Cathepsin G activity lowers plasma LDL and reduces atherosclerosis","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.11.030_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cvr\/cvq260","article-title":"Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in apoE-\/- mice","volume":"89","author":"Bot","year":"2011","journal-title":"Cardiovasc Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T09:04:36Z","timestamp":1560416676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017314156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"alternative-id":["S0021915017314156"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}